Paul J. Cimoch

A Double-Blind, Placebo-Controlled, Randomized, Clinical Trial of the TLR-3 Agonist Rintatolimod in Severe Cases of Chronic Fatigue Syndrome

David R. Strayer, William A. Carter, Bruce C. Stouch et al. · PLoS ONE · 2012 · 84 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +12

Pharmacokinetics of Oral Ganciclovir Alone and in Combination With Zidovudine, Didanosine, and Probenecid in HIV-Infected Subjects

Paul J. Cimoch, James P. Lavelle, Richard B. Pollard et al. · Journal of Acquired Immune Deficiency Syndromes & Human Retrovirology · 1998 · 52 citations

Pharmacy, Pharmacokinetics, Pharmacology +17

The in vitro immunomodulatory effects of glyconutrients on peripheral blood mononuclear cells of patients with chronic fatigue syndrome

Darryl M. See, Paul J. Cimoch, Shioweh Chou et al. · Integrative Psychological and Behavioral Science · 1998 · 27 citations

Life Sciences, Immunology, Nutritional Sciences +10

Antiviral activity and safety of aplaviroc, a CCR5 antagonist, in combination with lopinavir/ritonavir in HIV‐infected, therapy‐naïve patients: results of the EPIC study (CCR100136)^*

P. Yéni, Anthony LaMarca, Daniel Berger et al. · HIV Medicine · 2009 · 15 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17